Table 2 Semiology of epileptic events in the affected population.
[n] | |
|---|---|
Medical treatment at the timepoint of MRI | |
Phenobarbital | 9 |
Potassium bromide | 4 |
Levetiracetam | 3 |
Imepitoin | 1 |
Type of therapy | |
Mono | 2 |
Double | 5 |
Triple | 2 |
Special diet or dietary supplement before MRI | |
Medium chain triglycerides | 2 |
Cannabidiol | 2 |
Time between first seizure to MRI | |
< 1 month | 2 |
> 1–3 months | 6 |
> 3–12 months | 6 |
> 12 months | 3 |
Time between last reported seizure to MRI | |
2–7 days | 6 |
8–31 days | 11 |
Seizures | |
Status epilepticus | 1 |
Cluster seizures | 6 |
Seizure semiology | |
Tonic–clonic | 16 |
Tonic | 1 |
Focal onset secondary generalisation | 9 |
Unknown onset | 8 |
Additional focal seizures | 1 |
Autonomic signs | |
Salivation | 9 |
Urination | 11 |
Defecation | 5 |
Postictal aggression | 4 |
Interictal behavioural changes | |
Anxiety | 3 |
